Carlsmed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	73.12	85.89	40.23	7.37
Short-Term Investments	24	24	-	-
Cash & Short-Term Investments	97.12	109.89	40.23	7.37
Cash Growth	123.09%	173.20%	445.65%	-
Accounts Receivable	12.27	11.36	6.77	3.17
Inventory	2.06	1.85	1	0.58
Other Current Assets	3.96	3.57	1.37	0.65
Total Current Assets	115.41	126.67	49.35	11.77
Net Property, Plant & Equipment	3.26	3.31	1.9	2.24
Other Long-Term Assets	0.1	0.13	0.57	0.02
Total Assets	118.77	130.12	51.82	14.02
Accounts Payable	2.95	4.48	2.41	1.69
Accrued Expenses	5.99	9.05	5.96	3.6
Current Portion of Long-Term Debt	-	-	-	1.84
Current Portion of Leases	0.78	0.75	0.45	0.31
Total Current Liabilities	9.72	14.28	8.82	7.44
Long-Term Debt	15.36	15.35	15.41	7.47
Long-Term Leases	1.12	1.32	1.32	1.77
Other Long-Term Liabilities	0.33	0.31	0.68	0.1
Total Long-Term Liabilities	16.81	16.97	17.41	9.34
Total Liabilities	26.52	31.25	26.23	16.78
Additional Paid-in Capital	201.75	199.67	0.54	0.78
Retained Earnings	-109.5	-100.81	-71.17	-46.91
Total Common Shareholders' Equity	92.25	98.87	-70.63	-46.13
Minority Interest	-	-	96.23	43.38
Shareholders' Equity	92.25	98.87	25.6	-2.75
Total Liabilities & Equity	118.77	130.12	51.82	14.02
Total Debt	17.26	17.41	17.18	11.39
Net Cash (Debt)	79.86	92.48	23.05	-4.02
Net Cash Growth	-13.64%	301.30%	-	-
Net Cash Per Share	4.04	6.50	5.67	-1.03
Book Value	92.25	98.87	-70.63	-46.13
Book Value Per Share	4.66	6.95	-17.37	-11.87
Tangible Book Value	92.25	98.87	-70.63	-46.13
Tangible Book Value Per Share	4.66	6.95	-17.37	-11.87

SEC Filings: 10-K · 10-Q